Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial

Bibliographic Details
Title: Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial
Authors: Palumbo, Antonio, Bringhen, Sara, Petrucci, Maria Teresa, Musto, Pellegrino, Rossini, Fausto, Nunzi, Martina, Lauta, Vito Michele, Bergonzi, Cesare, Barbui, Anna, Caravita, Tommaso, Capaldi, Antonio, Pregno, Patrizia, Guglielmelli, Tommasina, Grasso, Mariella, Callea, Vincenzo, Bertola, Alessandra, Cavallo, Federica, Falco, Patrizia, Rus, Cecilia, Massaia, Massimo, Mandelli, Franco, Carella, Angelo Michele, Pogliani, Enrico, Liberati, Anna Marina, Dammacco, Franco, Ciccone, Giovannino, Boccadoro, Mario *
Source: In Blood 15 November 2004 104(10):3052-3057
Database: ScienceDirect
More Details
ISSN:00064971
DOI:10.1182/blood-2004-02-0408
Published in:Blood
Language:English